Form 4 holding
SVP, Chief Operations Officer
Anika Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 20,654
- Estimated value
- $328,605
- Report date
- 17 Mar 2025
- Price
- $15.91
- Ownership
- Direct
Anne Nunes - SVP, Chief Operations Officer at Anika Therapeutics, Inc.
Issuer-level insider activity
- Role
- SVP, Chief Operations Officer
- Issuer ticker
- ANIK on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Anne Nunes since 27 Sep 2025
Reported holdings for Anne Nunes in Anika Therapeutics, Inc.
Form 4 holding
SVP, Chief Operations Officer
Anika Therapeutics, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 10,912
- Estimated value
- $281,420
- Report date
- 15 Mar 2024
- Price
- $25.79
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
SVP, Chief Operations Officer
Anika Therapeutics, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 7,275
- Estimated value
- $115,745
- Report date
- 17 Mar 2025
- Price
- $15.91
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
SVP, Chief Operations Officer
Anika Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 26,442
- Estimated value
- Report date
- 15 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Anne Nunes in Anika Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.